IMGN Financial Facts
Loss from operations: -38.84MResearch and development support: 1.35M
See Full Income Statement
Inventory: 2.03M
Total shareholders' equity: -122.54M
See Full Balance Sheet
Immunogen Inc. (IMGN) Earnings
|
Expand Research on IMGN
Next EPS Date | 4/25/24 *Est. | EPS Growth Rate | +100.0% *Last Qtr. |
---|---|---|---|
Average EPS % Beat Rate | +73.5% | Revenue Growth Rate | -100.0% *Last Qtr. |
Average % Move 1-Wk after EPS | +51.9% | Normal Earnings Time | Before Open |
Date | Qtr | EPS | Cons. | Surprise | Revs | Cons. | Gd. | 1-Week % | 1-Day % | Details | |
---|---|---|---|---|---|---|---|---|---|---|---|
1/27/11 | Q211 | -$0.21 | -$0.22 | +$0.01 | $4.2M | $4.07M | N/A | Details | |||
4/28/11 | Q311 | -$0.22 | -$0.23 | +$0.01 | $5.2M | $4.19M | N/A | Details | |||
8/3/11 | Q411 | -$0.23 | -$0.24 | +$0.01 | N/A | $4.41M | N/A | Details | |||
10/27/11 | Q112 | -$0.26 | -$0.22 | -$0.04 | $2.5M | $5.61M | N/A | Details | |||
1/27/12 | Q212 | -$0.17 | -$0.23 | +$0.06 | $7.6M | $5.43M | N/A | Details | |||
4/27/12 | Q312 | -$0.24 | -$0.25 | +$0.01 | $3.25M | $4.24M | N/A | Details | |||
8/3/12 | Q412 | -$0.29 | -$0.30 | +$0.01 | $2.95M | $3.26M | N/A | Details | |||
10/26/12 | Q113 | -$0.30 | -$0.25 | -$0.05 | $4.1M | $4.1M | N/A | Details |